## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -3.0% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($126.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 2)

**1. Invesco Ltd. Grows Stock Position in Globe Life Inc. $GL**
- Source: MarketBeat | 20251205T122301 | Bullish | Relevance: 100%
- Invesco Ltd. increased its stake in Globe Life Inc. by 3.9% in the second quarter, now owning 4.84% of the company's stock valued at $487.4 million. Several other institutional investors also adjusted their positions in Globe Life, with the stock currently holding a "Moderate Buy" consensus rating from analysts. Globe Life recently reported strong quarterly earnings and announced a quarterly dividend of $0.27 per share.

**2. Edgestream Partners L.P. Sells 39,976 Shares of Globe Life Inc. $GL**
- Source: MarketBeat | 20251205T101314 | Somewhat-Bullish | Relevance: 100%
- Edgestream Partners L.P. significantly reduced its stake in Globe Life Inc. (NYSE:GL) by selling 39,976 shares, cutting its position by 69.3% in the second quarter. Despite this, Globe Life reported strong quarterly earnings, beating analyst expectations, and management provided optimistic guidance for fiscal year 2026 EPS. The company maintains a "Moderate Buy" consensus rating from analysts, with shares trading near $130.84 and offering a quarterly dividend.

**3. Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation**
- Source: ACCESS Newswire | 20251204T170752 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL). Shareholders who bought Globe Life securities before May 8, 2019, and still hold them, are urged to contact the firm to join the investigation. The investigation focuses on whether Globe Life and its officers engaged in corporate wrongdoing.

**4. Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation**
- Source: MyWabashValley.com | 20251204T160948 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE: GL) securities. The investigation focuses on whether Globe Life and its officers engaged in corporate wrongdoing, targeting investors who bought shares before May 8, 2019, and still hold them. Shareholders are encouraged to contact the firm for more information and to assist with the investigation.

**5. Schroder Investment Management Group Cuts Stock Position in Globe Life Inc. $GL**
- Source: MarketBeat | 20251204T120920 | Neutral | Relevance: 100%
- Schroder Investment Management Group reduced its stake in Globe Life Inc. by 21.6% in Q2, selling 41,427 shares. Despite this, Globe Life exceeded Q3 EPS expectations and provided optimistic FY2025 and FY2026 EPS guidance, maintaining a "Moderate Buy" consensus rating from analysts. The company also announced a quarterly dividend of $0.27 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($3.74M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 8.8x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($3.7M), management confidence. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 0.48 |
| 52W Range | $107.25 - $147.83 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 8.8 |
| Current P/E | 9.0 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.2% to -3.0% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.0pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 44. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.04% (CS: 28) | Weak |
| RSI_14 | 43.8 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.992x | Below |
| vs SMA50 | 0.976x | Below |
| vs SMA200 | 1.014x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $131.37
- **Stop Loss:** $126.61 (3.6% risk)
- **Target:** $136.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 210
- **Position Value:** $27,587.70
- **Portfolio %:** 27.59%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*